The Hydropothecary Corporation (TSXV:THCX) has announced an agreement with Segra International Corp. to incorporate plant tissue culture propagation into the cannabis company’s production process.
Segra specializes in an industrial-scale cannabis micropropagation method known as plant tissue culture propagation. The process replaces traditional cloning by reducing the risk of pathogens, fungi, and other issues that can plague cultivators. Hydropothecary hopes that Segra’s tissue culture propagation technique can be used to increase yields.
Hydropothecary’s CEO and co-founder, Sebastien St-Louis, says in the statement, “Working with Segra will allow us to meet one of the biggest challenges as we meet the demand for cannabis products across Canada and beyond, balancing quality and quantity in our cannabis production. Thanks to Segra’s plant tissue culture technique, we will scale up our production process while maintaining the industry-leading quality standards that have made us so successful.”
President and CEO of Segra, Todd McMurray is quoted in the statement saying, “We are honoured to be working with Hydropothecary. Our companies both have well-earned reputations for innovation and quality in our respective fields. This agreement is the perfect combination of skills and expertise to produce great-quality cannabis products for customers.”
With Canada’s recreational cannabis market expected to begin this summer, Hydropothecary hopes to complete planned facility expansions and thereby increase annual production capacity to 108,000 kg of